Healthcare Social Media Regulatory Compliance Audit Checklist
Audit pharmaceutical and medical device social media content against strict regulatory fair-balance and FDA/EMA standards before publication.
Use this template prior to launching disease awareness campaigns, brand activations, or unbranded health education across social networks. It ensures every post rigorously meets promotional compliance, safety reporting, and claim substantiation requirements.
Role: Senior Medical Regulatory Affairs Director and Healthcare Social Communications Strategist
Context
- Therapeutic category and indication: {{therapeutic_area}}
- Target reader profile: {{target_audience_segment}}
- Deployment channels: {{social_platform_list}}
- Clinical data backing core statements: {{primary_claim_evidence}}
- Pharmacovigilance handling workflow: {{adverse_event_protocol}}
- Governing regulatory framework: {{regulatory_jurisdiction}}
Task
Deliver an exhaustive pre-publication compliance checklist that evaluates draft social media assets against regulatory statutes, ensuring fair balance, appropriate safety disclosures, and risk mitigation across all scheduled channel touchpoints.
Method
- Review draft copy and creative assets against approved labeling and {{primary_claim_evidence}} for {{therapeutic_area}}.
- Verify the prominence and readability of risk disclosures alongside efficacy claims to confirm strict fair balance across {{social_platform_list}}.
- Cross-examine target audience framing against {{target_audience_segment}} to avoid off-label implications or misdirected therapeutic messaging.
- Audit character constraints, alt-text, pinned comments, and link-out destinations to guarantee immediate access to complete prescribing information.
- Evaluate visual assets, video storyboards, and audio tracks for non-verbal overstatement of clinical benefits.
- Integrate {{adverse_event_protocol}} compliance triggers for active community management, comment moderation, and escalation within {{regulatory_jurisdiction}}.
- Structure verification checkpoints into phased operational gates (Content Accuracy, Fair Balance, Link Integrity, and Pharmacovigilance Preparedness).
Constraints
- MUST cite specific regulatory mechanisms applicable under {{regulatory_jurisdiction}}.
- MUST NOT approve standalone benefit claims without companion risk information within visible viewport boundaries.
- Checkpoints MUST include binary pass/fail criteria alongside required remediation notes.
- Content must differentiate between branded promotional assets and unbranded disease state education.
Output format
- Executive Summary (max 150 words)
- Phased Audit Checklist (4 distinct categorical tables with Columns: Item #, Checkpoint Description, Verification Criteria, Risk Severity [High/Medium/Low], Compliance Status [Pass/Fail])
- Adverse Event Moderation Protocol Checklist (5-8 sequential items)
- Sign-off Approval Matrix
Self-review
- Are all 6 contextual variables explicitly operationalized within the checklist criteria?
- Is fair balance verifiably enforceable across visual, textual, and linked elements?
- Does the checklist provide unambiguous pass/fail boundaries for regulatory reviewers?
Explicit role, a named task, and discrete steps the model can follow.
Background, inputs and variables the model needs before it starts.
Hard boundaries — what the model must and must not do.
A named, field-level shape for the response.
Ordered work items that force analysis before an answer.
Length and structure that travel across frontier models.
Signal density — instruction weight without padding.
Documented variables so the scaffold adapts to new inputs.
Quality bar, assumptions and behaviour when inputs are thin.
How much real usage the template has behind it.